Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001851416 | SCV002301525 | likely pathogenic | Jeune thoracic dystrophy | 2021-09-23 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 446587). This variant has been observed in individual(s) with clinical features of short-rib thoracic dysplasia with or without polydactyly (Invitae). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with proline at codon 2910 of the DYNC2H1 protein (p.Leu2910Pro). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and proline. |
Dan Cohn Lab, |
RCV001291172 | SCV000611981 | pathogenic | Asphyxiating thoracic dystrophy 3 | 2017-06-01 | no assertion criteria provided | research | |
University of Washington Center for Mendelian Genomics, |
RCV001291172 | SCV001479571 | likely pathogenic | Asphyxiating thoracic dystrophy 3 | no assertion criteria provided | research |